What is the Fiscal Year for Precision BioSciences?
Date: November 13, 2026
Precision BioSciences's current fiscal year starts on May 22, 2026, and ends on May 21, 2027. Their current quarter is Q2, which ends on November 21, 2026.
Current Fiscal Year Overview
Fiscal Year Start
May 22, 2026
Fiscal Year End
May 21, 2027
Current Quarter
Q2
Current Quarter End
November 21, 2026
Quarterly Breakdown
Q1
May 22, 2026 – Aug 21, 2026
Q2
Aug 22, 2026 – Nov 21, 2026
Q3
Nov 22, 2026 – Feb 21, 2027
Q4
Feb 22, 2027 – May 21, 2027
Company Information
Headquarters
Durham, North Carolina
Industry
Biotechnology Research
Stock Symbol
DTIL
Description
Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Precision BioSciences and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.